Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease
Our data suggest improved long-term control of acute and chronic GvHD by combining Ruxo plus ECP compared with Ruxo alone.
Authors
- Iyad Sultan (ORCID: https://orcid.org/0000-0002-2664-1565)
- Rozan Alfar
- Isra Muradi
- Husam Abu Jazar
- Ahmad Abu‐Khader (ORCID: https://orcid.org/0000-0002-8940-8170)
- Lina Halahleh
- Zaid Abdel Rahman
- Eman Khattab
- Khalid Halahleh
Institutions
- Al-Ahliyya Amman University (JO)
- Al-Quds University (PS)
- King Hussein Cancer Center (JO)
Publication Details
- Journal
- Journal of Clinical Medicine Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.14740/jocmr6385
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00